Personalized medical intervention is in a transformative phase as artificial intelligence algorithms are increasingly deployed to tailor treatments for individual patients based on their unique characteristics.
Developers face the task of adequately protecting AI-based technologies under current US patent jurisprudence. Enablement and necessary disclosures to obtain patents related to AI are one such challenge.
Originally published in Bloomberg Law - July 15, 2024.
Please see full publication below for more information.
